Stock Scorecard



Stock Summary for Qiagen NV (QGEN) - $41.08 as of 4/26/2024 3:40:49 PM EST

Total Score

11 out of 29

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for QGEN

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for QGEN

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for QGEN

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2

Bonus Criteria for QGEN

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Latest News for for QGEN

Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week - Invesco QQQ Trust, Series 1 ( NASDAQ:QQQ ) , SPDR S&P 500 ( ARCA:SPY ) 4/29/2024 5:51:00 AM
Unveiling Qiagen ( QGEN ) Q1 Outlook: Wall Street Estimates for Key Metrics 4/24/2024 1:15:00 PM
Global Radioimmunoassay Market to Grow at a Minimal CAGR of ~3% by 2030 | DelveInsight 4/18/2024 9:31:00 PM
QIAGEN N.V. to release results for Q1 2024 and hold webcast 4/9/2024 1:48:00 PM
Companion Diagnostics Market Worth $13.6 billion | MarketsandMarkets™ 4/5/2024 2:30:00 PM
QIAGEN ( QGEN ) Boosts Cancer Research Suite With New Launches 4/4/2024 5:22:00 PM
DNA Methylation Detection Technology Markets, 2033 - Intensified Competition, Increasing Adoption, PCR Dominates 3/30/2024 1:45:00 AM
Global Sample Preparation Market Analysis and Outlook 2023-2030 Featuring Profiles of Agilent Technologies, Bio-Rad Labs, Danaher Corp, Illumina, Merck, and Other Key Players 3/29/2024 10:30:00 AM
World Molecular Diagnostics for Cancer Markets, 2023-2024 and 2027 with Profiles of Over 120 Companies 3/28/2024 10:15:00 AM
Food Diagnostics Market Size, Share, Growth Drivers, Segmentation, and Leading Players 3/27/2024 1:30:00 PM

Financial Details for QGEN

Company Overview

Ticker QGEN
Company Name Qiagen NV
Country USA
Description QIAGEN NV provides sample-to-knowledge solutions that transform biological materials into molecular knowledge globally. The company is headquartered in Venlo, the Netherlands.
Sector Name LIFE SCIENCES
Industry Name BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Most Recent Quarter 12/31/2023
Next Earnings Date 4/30/2024

Stock Price History

Last Day Price 41.08
Last Day Price Updated 4/26/2024 3:40:49 PM EST
Last Day Volume 0
Average Daily Volume 886,594
52-Week High 47.74
52-Week Low 34.77
Last Price to 52 Week Low 18.15%

Valuation Measures

Trailing PE 27.40
Industry PE 64.46
Sector PE 56.64
5-Year Average PE 17.53
Free Cash Flow Ratio 13.60
Industry Free Cash Flow Ratio 20.47
Sector Free Cash Flow Ratio 30.65
Current Ratio Most Recent Quarter 1.99
Total Cash Per Share 3.02
Book Value Per Share Most Recent Quarter 17.20
Price to Book Ratio 2.34
Industry Price to Book Ratio 7.85
Sector Price to Book Ratio 22.15
Price to Sales Ratio Twelve Trailing Months 4.53
Industry Price to Sales Ratio Twelve Trailing Months 9.94
Sector Price to Sales Ratio Twelve Trailing Months 5.17

Share Statistics

Total Shares Outstanding 221,357,000
Market Capitalization 9,093,345,560
Institutional Ownership N/A

Dividends

Ex-Dividend Date 1/30/2024
Last Dividend Amount 0.00
Current Dividend Amount 1.28
Dividend Aristocrat? False
Trailing Annual Dividend Rate 1.28
Trailing Annual Dividend Yield 3.07%
Forward Annual Dividend Rate 1.28
Forward Annual Dividend Yield 3.07%
5-Year Dividend Payments Count 1
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio 84.21%

Income Statement

Quarterly Earnings Growth YOY 8.90%
Annual Earnings Growth -19.35%
Reported EPS 12 Trailing Months 1.52
Reported EPS Past Year 0.00
Reported EPS Prior Year 2.07
Net Income Twelve Trailing Months 341,303,000
Net Income Past Year 341,303,000
Net Income Prior Year 423,211,000
Quarterly Revenue Growth YOY 2.20%
5-Year Revenue Growth 5.53%

Balance Sheet

Total Cash Most Recent Quarter 668,084,000
Total Cash Past Year 668,084,000
Total Cash Prior Year 730,669,000
Net Cash Position Most Recent Quarter -253,740,000
Net Cash Position Past Year -253,740,000
Long Term Debt Past Year 921,824,000
Long Term Debt Prior Year 1,471,898,000
Total Debt Most Recent Quarter 921,824,000
Equity to Debt Ratio Past Year 0.81
Equity to Debt Ratio Most Recent Quarter 0.81
Total Stockholder Equity Past Year 3,807,764,000
Total Stockholder Equity Prior Year 3,466,611,000
Total Stockholder Equity Most Recent Quarter 3,807,764,000

Options

Put/Call Ratio 0.06
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -0.59
MACD Signal -0.74
20-Day Bollinger Lower Band 40.28
20-Day Bollinger Middle Band 43.18
20-Day Bollinger Upper Band 46.08
Beta 0.42
RSI 44.92
50-Day SMA 42.95
200-Day SMA 47.62

System

Modified 4/27/2024 9:47:36 AM EST